Amgen insider plans sale of 516,775 shares

Rachna Khosla, affiliated with Amgen Inc., has filed a Form 144 indicating an intention to sell up to 516,775 shares of Amgen common stock through Fidelity Brokerage Services LLC, with an approximate sale date of 08/13/2026 on NASDAQ.

Rhea-AI Filing Summary

Rachna Khosla, affiliated with Amgen Inc., has filed a Form 144 indicating an intention to sell up to 516,775 shares of Amgen common stock through Fidelity Brokerage Services LLC, with an approximate sale date of 08/13/2026 on NASDAQ. The securities are reported as acquired on 08/11/2026 via a stock option exercise from the issuer as compensation. Over the past three months, Khosla has already sold 2,000 shares of Amgen common stock for gross proceeds of $825,084.05.

Key Figures

Shares to be sold: 516,775 shares Approximate sale date: 08/13/2026 Shares sold in past 3 months: 2,000 shares +2 more

5 metrics

Shares to be sold 516,775 shares Common stock proposed for sale under Form 144

Approximate sale date 08/13/2026 Planned date for sale of common stock

Shares sold in past 3 months 2,000 shares Common stock sold during the past three months

Gross proceeds past 3 months $825,084.05 Proceeds from 2,000 shares of Amgen common stock sold

Acquisition date of reported shares 08/11/2026 Stock option exercise from issuer as compensation

Key Terms

Form 144, stock option exercise, gross proceeds, approximate sale date

4 terms

Form 144 regulatory

"Rachna Khosla has filed a Form 144 indicating an intention to sell"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

stock option exercise financial

"acquired on 08/11/2026 via a stock option exercise from the issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

gross proceeds financial

"has already sold 2,000 shares of Amgen common stock for gross proceeds of $825,084.05"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

approximate sale date financial

"with an approximate sale date of 08/13/2026 on NASDAQ"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filed for AMGN disclose?

The Form 144 discloses that Rachna Khosla may sell up to 516,775 shares of Amgen common stock through Fidelity Brokerage, with an approximate sale date of 08/13/2026 on NASDAQ.

How many AMGN shares is Rachna Khosla planning to sell?

Rachna Khosla has indicated a potential sale of up to 516,775 shares of Amgen common stock, as recorded in the Form 144 under securities proposed to be sold.

When were the AMGN shares in this Form 144 acquired?

The shares covered by the Form 144 are reported as acquired on 08/11/2026 through a stock option exercise from Amgen Inc. as compensation.

What AMGN share sales occurred in the last three months?

Over the past three months, the filer has sold 2,000 shares of Amgen common stock, generating gross proceeds of $825,084.05, as reported in the securities sold during the past three months section.

Which broker and exchange are involved in the planned AMGN sale?

The planned sale is through Fidelity Brokerage Services LLC, with the Amgen common stock expected to be traded on NASDAQ, according to the Form 144 securities information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 11:14 AM Accepted by SEC EDGAR 08/13/2026 - 11:14 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001881332
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AMGEN INC
SEC File Number	001-37702
Address of Issuer	ONE AMGEN CENTER DRIVE THOUSAND OAKS CALIFORNIA 91320
Phone	(805)447-1000
Name of Person for Whose Account the Securities are To Be Sold	Khosla Rachna
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	1252	516775.00	540632005	08/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/11/2026	Stock Option Exercise	Issuer			1252	08/11/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Rachna Khosla One Amgen Center Drive Thousand Oaks CA 91320	Amgen Inc.	08/11/2026	2000	825084.05

144: Remarks and Signature

Remarks
Date of Notice	08/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christian Nasser as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Rachna Khosla
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)